Pharma Company Expands Capabilities with New Peptide Research Center Pharma Company Expands Capabilities with New Peptide Research Center The company's Price-Earnings (PE) Ratio stands at 165.54. DSIJ Intelligence / Saturday, April 5, 2025 0 154 Article rating: 3.9 Major public shareholders include Tpg Asia Vii Sf Pte Ltd with 24.78 per cent, HBM Private Equity India with 1.99 per cent, Anitha Rudraraju Nandyala with 1.73 per cent, Raju Penmasta with 1.11 per cent and Penmasta Aruna with 1.02 per cent. Read more